Cardiac Sarcoplasmic Reticulum Calcium Release and Load Are Enhanced by Subcellular cAMP Elevations in PI3Kγ-Deficient Mice
- 27 May 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 96 (10) , 1079-1086
- https://doi.org/10.1161/01.res.0000168066.06333.df
Abstract
We recently showed that phosphoinositide-3-kinase-γ–deficient (PI3Kγ−/−) mice have increased cardiac contractility without changes in heart size compared with control mice (ie, PI3Kγ+/+ or PI3Kγ+/−). In this study, we show that PI3Kγ−/− cardiomyocytes have elevated Ca2+ transient amplitudes with abbreviated decay kinetics compared with control under field-stimulation and voltage-clamp conditions. When Ca2+ transients were eliminated with high Ca2+ buffering, L-type Ca2+ currents (ICa,L), K+ currents, and action potential duration (APD) were not different between the groups, whereas, in the presence of Ca2+ transients, Ca2+-dependent phase of ICa,L inactivation was abbreviated and APD at 90% repolarization was prolonged in PI3Kγ−/− mice. Excitation-contraction coupling (ECC) gain, sarcoplasmic reticulum (SR) Ca2+ load, and SR Ca2+ release fluxes measured as Ca2+ spikes, were also increased in PI3Kγ−/− cardiomyocytes without detectable changes in Ca2+ spikes kinetics. The cAMP inhibitor Rp-cAMP eliminated enhanced ECC and SR Ca2+ load in PI3Kγ−/− without effects in control myocytes. On the other hand, the β-adrenergic receptor agonist isoproterenol increased ICa,L and Ca2+ transient equally by ≈2-fold in both PI3Kγ−/− and PI3Kγ+/− cardiomyocytes. Our results establish that PI3Kγ reduces cardiac contractility in a highly compartmentalized manner by inhibiting cAMP-mediated SR Ca2+ loading without directly affecting other major modulators of ECC, such as AP and ICa,L.Keywords
This publication has 40 references indexed in Scilit:
- Phosphoinositide 3-kinase γ controls autonomic regulation of the mouse heart through Gi-independent downregulation of cAMP levelFEBS Letters, 2004
- The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and diseaseJournal of Molecular and Cellular Cardiology, 2004
- The phosphoinositide 3-kinase inhibitor LY294002 enhances cardiac myocyte contractility via a direct inhibition of Ik,slow currentsCardiovascular Research, 2004
- Inhibition of Calcineurin and Sarcolemmal Ca 2+ Influx Protects Cardiac Morphology and Ventricular Function in K v 4.2N Transgenic MiceCirculation, 2002
- Alterations in action potential profile enhance excitation‐contraction coupling in rat cardiac myocytesThe Journal of Physiology, 2001
- Compartmentation of G Protein-Coupled Signaling Pathways in Cardiac MyocytesAnnual Review of Pharmacology and Toxicology, 2001
- Wortmannin, a PI3-Kinase Inhibitor: Promoting Effect on Insulin Secretion from Pancreatic β Cells through a cAMP-Dependent PathwayBiochemical and Biophysical Research Communications, 2000
- Relationship between K+ channel down‐regulation and [Ca2+]i in rat ventricular myocytes following myocardial infarctionThe Journal of Physiology, 1999
- Direct measurement of SR release flux by tracking ‘Ca2+ spikes’ in rat cardiac myocytesThe Journal of Physiology, 1998
- Targeting the Receptor-G q Interface to Inhibit in Vivo Pressure Overload Myocardial HypertrophyScience, 1998